FTRE
Price
$10.02
Change
+$0.17 (+1.73%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
894.38M
76 days until earnings call
SYRE
Price
$16.63
Change
+$0.13 (+0.79%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
996.01M
65 days until earnings call
Interact to see
Advertisement

FTRE vs SYRE

Header iconFTRE vs SYRE Comparison
Open Charts FTRE vs SYREBanner chart's image
Fortrea Holdings
Price$10.02
Change+$0.17 (+1.73%)
Volume$21.78K
Capitalization894.38M
Spyre Therapeutics
Price$16.63
Change+$0.13 (+0.79%)
Volume$8.2K
Capitalization996.01M
FTRE vs SYRE Comparison Chart in %
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. SYRE commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Buy and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (FTRE: $9.85 vs. SYRE: $16.49)
Brand notoriety: FTRE and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 162% vs. SYRE: 64%
Market capitalization -- FTRE: $908.91M vs. SYRE: $1B
FTRE [@Biotechnology] is valued at $908.91M. SYRE’s [@Biotechnology] market capitalization is $1B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 3 TA indicator(s) are bullish while SYRE’s TA Score has 6 bullish TA indicator(s).

  • FTRE’s TA Score: 3 bullish, 4 bearish.
  • SYRE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than FTRE.

Price Growth

FTRE (@Biotechnology) experienced а +18.18% price change this week, while SYRE (@Biotechnology) price change was -5.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

FTRE is expected to report earnings on Nov 17, 2025.

SYRE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($996M) has a higher market cap than FTRE($894M). SYRE YTD gains are higher at: -29.167 vs. FTRE (-47.185). SYRE has higher annual earnings (EBITDA): -222.15M vs. FTRE (-858.4M). SYRE has more cash in the bank: 527M vs. FTRE (81.2M). SYRE has less debt than FTRE: SYRE (0) vs FTRE (1.24B). FTRE has higher revenues than SYRE: FTRE (2.73B) vs SYRE (0).
FTRESYREFTRE / SYRE
Capitalization894M996M90%
EBITDA-858.4M-222.15M386%
Gain YTD-47.185-29.167162%
P/E RatioN/A1.68-
Revenue2.73B0-
Total Cash81.2M527M15%
Total Debt1.24B0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FTRESYRE
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
78%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
71%
Bearish Trend 5 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
72%
Bearish Trend 5 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
72%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
85%
Aroon
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 5 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCPIX48.01-0.15
-0.31%
Calvert Mid-Cap I
JMCRX22.39-0.18
-0.80%
James Micro Cap
TSOHX15.62-0.13
-0.83%
Nuveen International Res Eq I
UMLGX7.71-0.09
-1.15%
Columbia Select Large Cap Growth Inst
URNQX57.81-0.70
-1.20%
Victory Nasdaq 100 Index R6

FTRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FTRE has been loosely correlated with TECH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FTRE jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+2.07%
TECH - FTRE
44%
Loosely correlated
+0.55%
SYRE - FTRE
41%
Loosely correlated
-1.38%
DNLI - FTRE
41%
Loosely correlated
-2.43%
JAZZ - FTRE
40%
Loosely correlated
+1.28%
ADVM - FTRE
40%
Loosely correlated
+1.65%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-1.38%
IDYA - SYRE
61%
Loosely correlated
-1.52%
CGON - SYRE
60%
Loosely correlated
+0.39%
BEAM - SYRE
58%
Loosely correlated
-2.91%
XNCR - SYRE
57%
Loosely correlated
+0.99%
CRNX - SYRE
55%
Loosely correlated
+1.11%
More